Levetiracetam Brown & Burk

Levetiracetam, the active ingredient in Levetiracetam Brown & Burk, is an anticonvulsant presented as an oral tablet for oral use. It is indicated for the treatment of partial, generalized tonic‑clonic, and myoclonic seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Brown & Burk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across EU and global markets. The product meets European pharmacopoeia standards and is manufactured under GMP conditions. It is distributed through a secure logistics network that maintains product integrity during transport.

Levetiracetam is an anticonvulsant used to control seizure activity in various epilepsy syndromes. - Partial seizures: Reduces frequency of focal onset seizures, improving seizure control. - Generalized tonic‑clonic seizures: Decreases occurrence of bilateral convulsive seizures in patients with generalized epilepsy. - Myoclonic seizures: Helps prevent sudden muscle jerks associated with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness - Fatigue - Headache - Nausea - Irritability - Somnolence

Serious or Rare Side Effects: - Severe allergic reactions (e.g., Stevens‑Johnson syndrome) - Mood changes including depression or suicidal thoughts - Hematologic abnormalities such as leukopenia - Rash with systemic involvement - Multifocal seizure worsening (rare)

When prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure safe use. - Renal impairment: Adjust dose based on creatinine clearance. - History of psychiatric disorders: Monitor for mood changes or depression. - Concomitant CNS depressants: Observe for additive sedation. - Pregnancy: Use only if potential benefit justifies potential risk; data are limited. - Elderly patients: Start at lower dose and titrate cautiously. - Store at ambient temperature: Keep below 25 °C, protect from moisture and light in original packaging.

Levetiracetam can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: May reduce levetiracetam plasma levels, decreasing effectiveness. - Phenobarbital: Can lower levetiracetam concentrations, requiring close monitoring.

Moderate Interactions (Monitor Closely): - Alcohol: May enhance central nervous system depression. - Other antiepileptic drugs (e.g., valproate, phenytoin): May require dose adjustments. - Oral contraceptives: Potentially reduced hormonal efficacy, advise alternative contraception.